Bayer secured three billion euros in equity from Apollo-managed funds. This deal involves its long-acting reversible contraceptives business. Apollo funds will take a minority stake while Bayer retains control. The financing strengthens Bayer's capital structure and financial flexibility. This transaction is expected to close in the third quarter of 2026.

Bayer secured three billion euros in equity from Apollo-managed funds. This deal involves its long-acting reversible contraceptives business. Apollo funds will take a minority…

Für die jahrelangen Glyphosat-Rechtsstreitigkeiten hat Bayer Milliarden ausgegeben und sich hoch verschuldet. Jetzt steigt Apollo bei einem Subunternehmen für Verhütungsmittel ein…

Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal